Oakley AJ, Lo Bello M, Battistoni A, Ricci G, Rossjohn J, Villar HO et al
Retatrutide : GI adverse events dose-dependent
With various options available, each with its unique characteristics, knowing how they differ can guide patients and healthcare providers in making informed decisions about treatment plans
Like GLP-1 rival Eli Lilly, which produces tirzepatide sold as Mounjaro for diabetes and Zepbound for weight loss Novo has struggled to meet booming demand for the revolutionary drugs, which are beginning to show promise in a range of other areas too, including sleep apnea, heart problems, kidney disease and Parkinsons
GLP-1 injections like semaglutide and tirzepatide are powerful tools, but the real difference lies in how theyre managed
Hear Our Success Stories Follow us on Instagram and Facebook for the latest in wellness, weight loss, and mental health care